Nicholas Saraceno is Editor of Pharmaceutical Commerce. He can be reached at [email protected].
How Drug Shortages Could Disrupt Hospital Operations and Strain Patient Care
September 5th 2025In the first part of their Pharma Commerce video interview Diogo Rau, executive vice president and chief information and digital officer for Eli Lilly and Company, Boyede Sobitan and Annika Matas of Zebra Technolgies warn that ongoing medication shortages are forcing staff to borrow supplies, delay procedures, and divert nurses from patient care to logistical tasks, creating both financial pressures and operational inefficiencies.
Overcoming Barriers to Full e-Prescribing Adoption
September 4th 2025In the final part of his Pharma Commerce video interview, Diogo Rau, executive vice president and chief information and digital officer for Eli Lilly and Company, focuses on physician demand, global momentum, and how US legislation can help the industry finally move beyond paper.
Trump Pushes Supreme Court to Save Tariffs After Appeals Court Ruling Limits Presidential Power
September 4th 2025Following a federal appeals court decision that struck down much of his tariff authority under the International Emergency Economic Powers Act, President Trump is asking the Supreme Court to fast-track review.
Why Reducing Paper Inserts Is About Access as Much as Sustainability
September 3rd 2025In the second part of his Pharma Commerce video interview, Diogo Rau, executive vice president and chief information and digital officer for Eli Lilly and Company, highlights that cutting down on the 90 billion sheets of paper used for medicine inserts each year isn’t just an environmental win—it’s also a critical step toward making drug information more accessible for patients with vision challenges, language barriers, or cognitive and physical disabilities.
Amgen to Invest $600M in New Science and Innovation Center at California HQ
September 3rd 2025The company is committing over half a billion dollars to build a state-of-the-art research hub in Thousand Oaks, CA, designed to accelerate next-generation therapeutics through advanced automation and collaboration.
Modernizing Prescription Information
September 2nd 2025In the first part of his Pharma Commerce video interview, Diogo Rau, executive vice president and chief information and digital officer for Eli Lilly and Company, explains how the Prescription Information Modernization Act of 2025 aims to replace package inserts with digital-first documentation, providing patients with better access to understandable medication guidance in the process.
Balancing Tariffs and Patient Access in Pharma Policy
August 28th 2025In the final part of his Pharma Commerce video interview, Dave Malenfant, a healthcare supply chain expert, emphasizes that patient access must remain the top priority, even amid steep tariffs, citing cases like orphan drugs and oncology treatments where government flexibility is essential.
Pharma Supply Chain Faces Risks of Tariffs Driving Excess Inventory
August 27th 2025In the fourth part of his Pharma Commerce video interview, Dave Malenfant, a healthcare supply chain expert, cautions that stockpiling to offset tariffs could backfire for pharma companies, leading to expired inventory, higher waste, and costly trade-offs, unless renegotiation strategies are pursued.
DSCSA Distributor Exemption Ends, Marking Major Milestone in Pharma Supply Chain Security
August 27th 2025As of today, Aug. 27, wholesale distributors must fully comply with the Drug Supply Chain Security Act’s enhanced drug distribution requirements, closing the FDA’s exemption period and advancing efforts to strengthen patient safety and supply chain integrity.
EVERSANA, Waltz Health Form Combined Platform to Tackle Drug Costs and Access Challenges
August 27th 2025The merger integrates EVERSANA’s commercialization services with Waltz Health’s AI-powered payer tools to address patient affordability, streamline drug access, and reduce costs for high-expense therapies such as GLP-1s.
Genentech Breaks Ground on $700M North Carolina Manufacturing Facility
August 26th 2025The new 700,000-square-foot Holly Springs site—part of Roche’s $50 billion US investment plan—will focus on metabolic and obesity treatments, create 400 jobs, and strengthen domestic biopharma manufacturing amid shifting tariff and drug pricing policies.
Peer Exchange: Building the Next-Generation Supply Chain Talent Pipeline (Episode 9)
August 22nd 2025In the ninth part of this roundtable discussion, industry experts discuss how the pharma supply chain is evolving into an integrated business planning function, highlighting the need for diverse skill sets, digital dexterity, and AI-enabled capabilities to prepare Gen Z and future leaders for patient-centric problem solving.